SCHEMBL4771906

SCHEMBL4771906

COc1c(C)cccc1C1CC1C(=O)Nc1sc2c(c1C#N)CCNC2

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.44
ALDH1A1 P00352 5/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 2/20 0.42
HTT P42858 1/20 0.42
RECQL P46063 1/20 0.42
NPC1 O15118 4/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 3/20 0.40
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766038 0.92 POLB (0.48) POLBALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL4776039 0.91 MAPT (0.42) POLBALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL4963439 0.90 ALDH1A1 (0.43) POLBALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL4963443 0.90 ALDH1A1 (0.44) POLBALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL4766464 0.88 POLB (0.48) POLBALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL4960897 0.88 ALDH1A1 (0.43) POLBALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL2894804 0.87 NPC1 (0.49) POLBALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL4769353 0.87 POLB (0.50) POLBALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL4775000 0.86 ALDH1A1 (0.45) POLBALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL4767800 0.86 POLB (0.47) POLBALDH1A1SMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893618-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-05 EP disclosed
WO-2006125815-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 WO disclosed